PD Neurotechnology® has been certified by DQS Hellas with the ISO/IEC 27701:2019 Certificate. DQS Hellas issued this Confirmation after having assessed PD Neurotechnology®’s Privacy Information Management System to be in conformance with the requirements of ISO/IEC 27701:2019. This assessment was conducted along with ISO/IEC 27001:2013.

Prof Dimitris Fotiadis, R&D Director and Founder of PD Neurotechnology® commented: “We are very proud to receive the ISO/IEC 27701:2019. It is proof that our company operates the right way when it comes to matters of patient privacy and management of personal sensitive data.

Discover more about PD Neurotechnology Ltd:

PD Neurotechnology Ltd. is an awarded, high-tech medical device company, founded in London, UK in 2015, certified with ISO 9001:2015, ISO 27001:2013, ISO 27701:2019 and ISO 13485:2016. Its first product, PDMonitor® is a CE marked, Class IIa medical device, a digital, noninvasive, continuous monitoring system and management tool, used by patients with Parkinson’s Disease, which enables an accurate motor symptom evaluation, coupled with information on lifestyle and drug adherence. A web application offers the treating physician a comprehensive and objective view of the patient status and supports the assessment of the disease stage and prompt and optimal modification of the treatment. PDMonitor® is currently marketed in most European countries, soon to be available in the US and the Middle East.